GigaGen: GigaGen doses first subject in Phase I advanced solid tumour trial

GigaGen has dosed the first subject in a Phase I trial of GIGA-564 targeting metastatic or locally advanced solid tumours.The post GigaGen doses first subject in Phase I advanced solid tumour trial appeared first on Clinical Trials Arena.